[Updated M&A] Backed by Frist, Sumitomo, et al, digital therapeutics startup mulls Series B capital raise.
Engineering Dean sees opportunities to address large-scale global needs.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: